The blood transfusion diagnostics market size has grown strongly in recent years. It will grow from $4.96 billion in 2025 to $5.35 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited availability of advanced blood diagnostics instruments, reliance on manual blood grouping methods, increasing hospital blood transfusion procedures, growing prevalence of transfusion-transmissible infections, lack of standardized reagents and kits.
The blood transfusion diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of high-throughput automated blood screening systems, increasing demand for nucleic acid amplification and rapid tests, rising investment in blood banks and diagnostic laboratories, adoption of digital and AI-enabled diagnostic solutions, expansion of plasma fractionation and research activities. Major trends in the forecast period include rising demand for rapid and accurate blood typing, increasing adoption of automated blood processing systems, expansion of disease screening capabilities, growth in plasma fractionation and diagnostic laboratories, enhanced focus on standardization and quality control.
The growing number of surgical procedures is expected to propel the growth of the blood transfusion diagnostics market going forward. Surgical procedures are medical interventions performed to treat injuries, diseases, or disorders using manual or instrumental techniques. As the global volume of surgeries continues to rise, the demand for safe and compatible blood transfusions increases to replace blood lost during surgical interventions. Blood transfusion diagnostics play a vital role in screening and matching donor blood, preventing transfusion-related infections and complications, and ensuring patient safety while improving clinical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger procedures, totaled 207,887 cases, reflecting a 2% increase from 2022. Therefore, the rising number of surgical procedures is driving the growth of the blood transfusion diagnostics market.
The increasing prevalence of blood-related diseases is expected to drive the growth of the blood transfusion diagnostics market going forward. Blood-related diseases include disorders that affect blood composition, function, or production, such as anemia, leukemia, and clotting disorders. Blood transfusion diagnostics support early detection and safe management of these conditions by ensuring compatible blood products and reducing patient risk. For example, in January 2023, according to the American Cancer Society Inc., a US-based professional organization, approximately 59,610 new cases of leukemia and 23,710 leukemia-related deaths were reported, including about 20,380 new cases of acute myeloid leukemia. Therefore, the rising prevalence of blood-related diseases is contributing to the expansion of the blood transfusion diagnostics market.
Major companies operating in the blood transfusion diagnostics market are developing advanced technologies, including innovations in transfusion systems, to improve blood typing accuracy, enhance patient safety, reduce the risk of transfusion-transmitted infections, and streamline transfusion workflows. Innovations in transfusion technology encompass advancements in the methods, devices, and processes used in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, launched Omnys, a significant innovation in transfusion grouping and blood testing. Omnys is an advanced diagnostic platform designed to deliver rapid and precise blood typing, compatibility testing, and pathogen detection. This technology utilizes advanced biomarker identification and automation to optimize transfusion processes and ensure safe matching of blood products to patients.
Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.
North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood transfusion diagnostics market by increasing costs for imported instruments, reagents, and automated systems. Segments like automated blood processing systems and high-quality reagents are most impacted, particularly in Asia-Pacific regions such as China and India, which are major manufacturing hubs. These tariffs have led to higher production costs and potential delays in adoption. On the positive side, they encourage local manufacturing, development of alternative reagents, and investment in domestic diagnostic technologies.
The blood transfusion diagnostics market research report is one of a series of new reports that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood transfusion diagnostics involve tests performed before blood transfusion, such as blood typing and disease screening, to ensure compatibility and safety between donor and recipient.
The main types of blood transfusion diagnostics include instruments and kits, reagents, and others. Blood transfusion diagnostic kits are used for blood collection and transfusion processes. The technologies employed in blood transfusion diagnostics include western blot, ELISA, nucleic acid amplification tests, fluorescence assays, and rapid tests, which are used for applications such as blood typing and disease screening. The end users include hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies.
The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood transfusion diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of high-throughput automated blood screening systems, increasing demand for nucleic acid amplification and rapid tests, rising investment in blood banks and diagnostic laboratories, adoption of digital and AI-enabled diagnostic solutions, expansion of plasma fractionation and research activities. Major trends in the forecast period include rising demand for rapid and accurate blood typing, increasing adoption of automated blood processing systems, expansion of disease screening capabilities, growth in plasma fractionation and diagnostic laboratories, enhanced focus on standardization and quality control.
The growing number of surgical procedures is expected to propel the growth of the blood transfusion diagnostics market going forward. Surgical procedures are medical interventions performed to treat injuries, diseases, or disorders using manual or instrumental techniques. As the global volume of surgeries continues to rise, the demand for safe and compatible blood transfusions increases to replace blood lost during surgical interventions. Blood transfusion diagnostics play a vital role in screening and matching donor blood, preventing transfusion-related infections and complications, and ensuring patient safety while improving clinical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger procedures, totaled 207,887 cases, reflecting a 2% increase from 2022. Therefore, the rising number of surgical procedures is driving the growth of the blood transfusion diagnostics market.
The increasing prevalence of blood-related diseases is expected to drive the growth of the blood transfusion diagnostics market going forward. Blood-related diseases include disorders that affect blood composition, function, or production, such as anemia, leukemia, and clotting disorders. Blood transfusion diagnostics support early detection and safe management of these conditions by ensuring compatible blood products and reducing patient risk. For example, in January 2023, according to the American Cancer Society Inc., a US-based professional organization, approximately 59,610 new cases of leukemia and 23,710 leukemia-related deaths were reported, including about 20,380 new cases of acute myeloid leukemia. Therefore, the rising prevalence of blood-related diseases is contributing to the expansion of the blood transfusion diagnostics market.
Major companies operating in the blood transfusion diagnostics market are developing advanced technologies, including innovations in transfusion systems, to improve blood typing accuracy, enhance patient safety, reduce the risk of transfusion-transmitted infections, and streamline transfusion workflows. Innovations in transfusion technology encompass advancements in the methods, devices, and processes used in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, launched Omnys, a significant innovation in transfusion grouping and blood testing. Omnys is an advanced diagnostic platform designed to deliver rapid and precise blood typing, compatibility testing, and pathogen detection. This technology utilizes advanced biomarker identification and automation to optimize transfusion processes and ensure safe matching of blood products to patients.
Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.
North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood transfusion diagnostics market by increasing costs for imported instruments, reagents, and automated systems. Segments like automated blood processing systems and high-quality reagents are most impacted, particularly in Asia-Pacific regions such as China and India, which are major manufacturing hubs. These tariffs have led to higher production costs and potential delays in adoption. On the positive side, they encourage local manufacturing, development of alternative reagents, and investment in domestic diagnostic technologies.
The blood transfusion diagnostics market research report is one of a series of new reports that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood transfusion diagnostics involve tests performed before blood transfusion, such as blood typing and disease screening, to ensure compatibility and safety between donor and recipient.
The main types of blood transfusion diagnostics include instruments and kits, reagents, and others. Blood transfusion diagnostic kits are used for blood collection and transfusion processes. The technologies employed in blood transfusion diagnostics include western blot, ELISA, nucleic acid amplification tests, fluorescence assays, and rapid tests, which are used for applications such as blood typing and disease screening. The end users include hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies.
The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Transfusion Diagnostics Market Characteristics
3. Blood Transfusion Diagnostics Market Supply Chain Analysis
4. Global Blood Transfusion Diagnostics Market Trends and Strategies
5. Blood Transfusion Diagnostics Market Analysis of End Use Industries
7. Global Blood Transfusion Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Transfusion Diagnostics Total Addressable Market (TAM) Analysis for the Market
9. Blood Transfusion Diagnostics Market Segmentation
10. Blood Transfusion Diagnostics Market Regional and Country Analysis
11. Asia-Pacific Blood Transfusion Diagnostics Market
12. China Blood Transfusion Diagnostics Market
13. India Blood Transfusion Diagnostics Market
14. Japan Blood Transfusion Diagnostics Market
15. Australia Blood Transfusion Diagnostics Market
16. Indonesia Blood Transfusion Diagnostics Market
17. South Korea Blood Transfusion Diagnostics Market
18. Taiwan Blood Transfusion Diagnostics Market
19. South East Asia Blood Transfusion Diagnostics Market
20. Western Europe Blood Transfusion Diagnostics Market
21. UK Blood Transfusion Diagnostics Market
22. Germany Blood Transfusion Diagnostics Market
23. France Blood Transfusion Diagnostics Market
24. Italy Blood Transfusion Diagnostics Market
25. Spain Blood Transfusion Diagnostics Market
26. Eastern Europe Blood Transfusion Diagnostics Market
27. Russia Blood Transfusion Diagnostics Market
28. North America Blood Transfusion Diagnostics Market
29. USA Blood Transfusion Diagnostics Market
30. Canada Blood Transfusion Diagnostics Market
31. South America Blood Transfusion Diagnostics Market
32. Brazil Blood Transfusion Diagnostics Market
33. Middle East Blood Transfusion Diagnostics Market
34. Africa Blood Transfusion Diagnostics Market
36. Blood Transfusion Diagnostics Market Competitive Landscape and Company Profiles
37. Blood Transfusion Diagnostics Market Other Major and Innovative Companies
40. Blood Transfusion Diagnostics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Transfusion Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood transfusion diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood transfusion diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood transfusion diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Instruments And Kits; Reagents; Other Types2) By Technology: Western Blot; ELISA; Nucleic Acid Amplification; Fluorescence Assay; Rapid Test
3) By Application: Blood Grouping; Disease Screening
4) By End User: Hospitals; Diagnostic Laboratories; Blood Banks; Plasma Fractionation Companies
Subsegments:
1) By Instruments And Kits: Blood Typing Instruments; Cross-Matching Kits; Blood Screening Instruments; Automated Blood Processing Systems2) By Reagents: Antisera; Control Solutions; Blood Grouping Reagents; Enzymes And Other Reagents
3) By Other Types: Software Solutions; Consumables; Training And Support Services
Companies Mentioned: Fresenius Kabi AG; Becton Dickinson and Company; Baxter International Inc.; Medline Industries LP; Grifols SA; Terumo Corporation; Haemonetics Corporation; Sarstedt AG & Co KG; Cerus Corporation; Charter Medical Ltd; Kawasumi Laboratories Inc; Macopharma SA; GenesisBPS Inc; Werfen S.A; B Braun Melsungen AG; Immucor Inc; Kaneka Corporation; Nipro Medical Corporation; Teleflex Incorporated; Smiths Medical; HLL Lifecare Limited.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Transfusion Diagnostics market report include:- Fresenius Kabi AG
- Becton Dickinson and Company
- Baxter International Inc.
- Medline Industries LP
- Grifols SA
- Terumo Corporation
- Haemonetics Corporation
- Sarstedt AG & Co KG
- Cerus Corporation
- Charter Medical Ltd
- Kawasumi Laboratories Inc
- Macopharma SA
- GenesisBPS Inc
- Werfen S.A
- B Braun Melsungen AG
- Immucor Inc
- Kaneka Corporation
- Nipro Medical Corporation
- Teleflex Incorporated
- Smiths Medical
- HLL Lifecare Limited.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.35 Billion |
| Forecasted Market Value ( USD | $ 6.86 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
